Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
A novel triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors, demonstrating the highest weight loss of any anti-obesity medication tested to date in Phase 2 trials.
5 of 25 vendors lab-verified
Verified purity per dollar — the cheapest that's actually been tested
vial · 30mg· virtuspeptides.com· price updated 6d ago
Lot RT30-655· tested 2026-07-01· vendor-declared ✓
$75.00✓ $1.75/mg
10+ any items → 30% off · was $2.50/mg single
bulk $/mg · quantity break
vial · 30mg · 10-Pack· crushresearch.shop· price updated today
Lot CR-3XAG30-2606-Purple· tested 2026-07-02
$599.00✓ $2.00/mg
12% more per mg vs cheapest
multi-vial pack $/mg
vial · 30mg· peptideplugs.com· price updated today
$120.00✓ $2.40/mg
27% more per mg vs cheapest
10× same product → 40% off · was $4.00/mg single
bulk $/mg · quantity break
vial · 24mg · 480 mg· peptide.partners· price updated today
Lot RT202607· tested 2026-06-09
$1512.00✓ $3.15/mg
44% more per mg vs cheapest
multi-vial pack $/mg
vial · 60mg· ionpeptide.com· price updated today
$219.00✓ $2.74/mg
36% more per mg vs cheapest
10+ any items → 25% off · was $3.65/mg single
bulk $/mg · quantity break
vial · 20mg · 10-Pack· peptidesupplyco.com· price updated today
Lot RT2006102026· tested 2026-06-14
$480.00✓ $2.40/mg
27% more per mg vs cheapest
multi-vial pack $/mg
vial · 60mg· glacieraminos.shop· price updated today
$248.99✓ $2.90/mg
40% more per mg vs cheapest
30+ any items → 30% off · was $4.15/mg single
bulk $/mg · quantity break
vial · 62.41mg· peptidology.co· price updated today
$279.00✓ $3.35/mg
48% more per mg vs cheapest
40+ any items → 25% off · was $4.47/mg single
bulk $/mg · quantity break
vial · 50mg· milehighcompounds.is· price updated today
$299.99−7%
$279.99✓ $4.48/mg
61% more per mg vs cheapest
10+ any items → 20% off · was $5.60/mg single
bulk $/mg · quantity break
vial · 30mg· skyepeptides.com· price updated today
$209.00−5%
$199.00✓ $5.31/mg
67% more per mg vs cheapest
20+ any items → 20% off · was $6.63/mg single
bulk $/mg · quantity break
vial · 20mg· eternalpeptides.com· price updated today
$200.00−12%
$175.99✓ $7.48/mg
77% more per mg vs cheapest
21+ any items → 15% off · was $8.80/mg single
bulk $/mg · quantity break
30 vendors not shown — trust grade below C, or not enough verified COA data yet. We only list sources with a C grade or better.
Best price trend
Lowest $/mg for Retatrutide · verified listings only
$3.00/mg
▼ 35% over 90d
Virtus Peptides has the lowest single-vial Retatrutide price at $2.50/mg among 135 COA-verified vendors on Disclosed Labs. Bulk or multi-vial deals may be lower. That's 80% less per mg than the most expensive option.
What is the price range for Retatrutide?
Research-grade Retatrutide ranges from $2.50/mg to $12.50/mg across 26 verified sources, a 80% spread per mg.
How are Retatrutide prices verified on Disclosed Labs?
Every listed vendor holds a Grade C or better trust score, computed independently from lab Certificates of Analysis — not from payments or sponsorships. Prices are scraped and fact-checked daily. Vendors cannot pay to improve their ranking.
Check formulation: Lyophilized powder requires reconstitution before use. Pre-mixed solutions are more convenient but may have a shorter shelf life and higher prices.
Compare per-mg cost: Different strengths and quantities make direct price comparison difficult. Calculate the per-milligram cost to find the true best value.
Verify COAs: Look for vendors that publish per-batch Certificates of Analysis from named, accredited labs. Use the Full safety panel filter to require endotoxin, sterility, and heavy-metals testing on the current batch — not just HPLC purity.
Phase 2 obesity trial (Jastreboff et al., NEJM 2023; PMID 37366315) demonstrated up to 24.2% body weight loss at 48 weeks at the 12 mg dose, exceeding both semaglutide and tirzepatide. A Phase 2 type 2 diabetes trial (Rosenstock et al., Lancet 2023; PMID 37385280) showed robust HbA1c and weight reductions vs. placebo and dulaglutide. A Phase 2a MASLD trial (Sanyal et al., Nat Med 2024; PMID 38858523) demonstrated significant reductions in hepatic steatosis driven by glucagon receptor activation. Phase 3 TRIUMPH trials are ongoing (Eli Lilly), with results expected 2025–2026. Retatrutide is NOT FDA-approved as of April 2026 — it remains investigational.
This platform provides informational tools only, not medical advice.
Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial
2023
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA
2023
Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial
Prices verified as of July 2026. Actual prices may vary. For research use only.
Single-vial list prices by default for a fair head-to-head — switch to Multi-vial / bulk for pack pricing. Estimates only; verify at vendor before purchase. For research use only. Not medical advice.
2024
Disclosed Labs